Sort
46,585 grants matching “heart failure”
Bioengineering a chimeric human lung
$842,444Gordana Vunjak-Novakovic · Columbia University Health Sciences · R01 · FY2022 · HL
Bioengineering a chimeric human lung
$842,444Gordana Vunjak-Novakovic · Columbia University Health Sciences · R01 · FY2020 · HL
Bioengineering a chimeric human lung
$842,444Gordana Vunjak-Novakovic · Columbia University Health Sciences · R01 · FY2021 · HL
Mechanistic Insights to A Translatable Therapy for Acute Reperfused Hemorrhagic Myocardial Infarctions
$842,413Rohan Dharmakumar · Cedars-Sinai Medical Center · R01 · FY2020 · HL
Mechanisms of Parkinson Disease and Related Disorders
$842,411David Goldstein · National Institute Of Neurological Disorders And Stroke · ZIA · FY2015 · NS
Avoiding (Heart) Failure: Physiologic-Based Targeting of the RAAS to Treat Subclinical HFpEF among PWH
$842,388Suman Srinivasa · Massachusetts General Hospital · R01 · FY2023 · HL
Avoiding (Heart) Failure: Physiologic-Based Targeting of the RAAS to Treat Subclinical HFpEF among PWH
$842,357Suman Srinivasa · Massachusetts General Hospital · R01 · FY2022 · HL
Unraveling Cytotoxic and Thrombotic Signals in COVID-19
$842,247Yogendra Kanthi · National Heart, Lung, And Blood Institute · ZIA · FY2024 · HL
Occluded Artery Trial: Long Term Follow-Up
$842,231Judith S Hochman · New York University School Of Medicine · U01 · FY2007 · HL
Pilot Clinical Study in Renal Transplantation
$842,216Weizhong Cai · Angion Biomedica Corporation · R44 · FY2009 · DK
IGF::OT::IGF ATHEROSCLEROSIS IN RISK COMMUNITIES - FIELD CENTER - CORE STUDY OPERATIONS
$842,093Josef Coresh · Johns Hopkins University · N01 · FY2021 · HL
Finding undiagnosed ATTR-CM patients using AI technology in clinical settings
$841,730Kelly D Myers · Atomo, Inc · R44 · FY2023 · HL
Look AHEAD: Action for Health in Diabetes
$841,575John M Jakicic · University Of Pittsburgh At Pittsburgh · U01 · FY2008 · DK
Small Molecule Therapeutics for Renal Disease
$841,379Prakash Narayan · Angion Biomedica Corporation · R44 · FY2009 · DK
Ventricular-vascular coupling in the elderly: lifecourse determinants, trajectories and prognostic significance
$841,114Vasan S. Ramachandran · Boston University Medical Campus · R01 · FY2019 · HL
Image Guided Delivery of Bioresponsive Hydrogels
$841,093Albert J Sinusas · Yale University · R01 · FY2018 · HL
Avoiding (Heart) Failure: Physiologic-Based Targeting of the RAAS to Treat Subclinical HFpEF among PWH
$840,829Suman Srinivasa · Massachusetts General Hospital · R01 · FY2024 · HL
Therapeutic Mechanisms of Cardiac Progenitors in Ischemic Cardiomyopathy
$840,689Roger J. Hajjar · Icahn School Of Medicine At Mount Sinai · R01 · FY2018 · HL
Therapeutic Mechanisms of Cardiac Progenitors in Ischemic Cardiomyopathy
$840,689Kenneth Michael Fish · Icahn School Of Medicine At Mount Sinai · R01 · FY2019 · HL
Therapeutic Mechanisms of Cardiac Progenitors in Ischemic Cardiomyopathy
$840,689Roger J. Hajjar · Icahn School Of Medicine At Mount Sinai · R01 · FY2017 · HL
Therapeutic Mechanisms of Cardiac Progenitors in Ischemic Cardiomyopathy
$840,689Kenneth Michael Fish · Icahn School Of Medicine At Mount Sinai · R01 · FY2020 · HL
Epidemiologic Determinants of Cardiac Structure and Function (ECHO-SOL2)
$840,602Carlos Jose Rodriguez · Wake Forest University Health Sciences · R56 · FY2015 · HL
CMR Myocardial Tissue Based Prediction of Ischemic MR Revascularization Response
$840,584Jonathan W. Weinsaft · Weill Medical Coll Of Cornell Univ · R01 · FY2015 · HL
Avoiding (Heart) Failure: Physiologic-Based Targeting of the RAAS to Treat Subclinical HFpEF among PWH
$839,988Suman Srinivasa · Massachusetts General Hospital · R01 · FY2021 · HL
Epidemiologic Determinants of Change in Cardiac Structure and Function (ECHO-SOL 2)
$839,877Carlos Jose Rodriguez · Wake Forest University Health Sciences · R01 · FY2016 · HL